EIP
XBI icon

Ellis Investment Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ellis Investment Partners’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405K Buy
2,560
+1
+0% +$135 0.06% 193
2026
Q1 		$327K Buy
2,559
+316
+14% +$39.4K 0.06% 204
2025
Q4 		$274K Buy
+2,243
New +$257K 0.05% 210

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Ellis Investment Partners's XBI Position: Q2 2026 in Review

Ellis Investment Partners increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.04% in Q2 2026, buying an estimated $135 and bringing the position to 2,560 shares worth $405K. The position accounts for 0.06% of the portfolio, ranked #193.

Ellis Investment Partners first reported a position in XBI in Q4 2025 and has held it in 3 quarters since. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Ellis Investment Partners held 2,560 shares of State Street SPDR S&P Biotech ETF worth $405K as of Q2 2026.
  • Ellis Investment Partners bought 1 State Street SPDR S&P Biotech ETF share in Q2 2026, an estimated $135.
  • State Street SPDR S&P Biotech ETF made up 0.06% of Ellis Investment Partners's portfolio in Q2 2026, its #193 holding.
  • Ellis Investment Partners first reported a position in State Street SPDR S&P Biotech ETF in Q4 2025 and has held it in 3 quarters since.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.